Key result
Fibrocartilaginous embolism in 67 cases emerges as an under-diagnosed cause of spinal cord infarction.
Fibrocartilaginous embolism is an under-studied and potentially under-diagnosed cause of spinal cord infarction that is often misdiagnosed as transverse myelitis.
Answers are grounded in this paper and cite their sources.
May warrant inclusion of fibrocartilaginous embolism in spinal infarction differentials; leaves open prospective validation and diagnostic criteria.
BACKGROUND: Most spinal cord infarctions are due to aortic pathologies and aortic surgeries. Fibrocartilaginous Embolism (FCE) has been reported to represent 5.5% of spinal cord infarctions. Some believe that FCE is more common than presumed and is rather under-diagnosed due to vagueness surrounding its clinical presentation. METHOD: A literature search was conducted for case reports of FCE published before August 2014. PubMed, the Cochrane Central Register and Google Scholar were searched for different combinations of the key words "fibrocartilaginous, "nucleus pulposus", "embolism", "spinal cord", "inter-vertebral disc", "infarction", "stroke", "paraplegia", "quadriplegia", "myelopathy". RESULT: Fifty-five case articles were reviewed, ten of which were translated from foreign languages. A total of 67 cases of FCE were found, 41 tissue-confirmed and 26 clinically suspected. A comprehensive summary of the clinical anatomy, patho-physiologic mechanisms, epidemiology, diagnosis and treatment of FCE is described, along with the conflicting opinions on its incidence and relevance after reviewing all of the related literature. The 41 tissue proven cases are summarized and a schematic approach to the clinical diagnosis of FCE, deducted from their clinical findings, is presented. CONCLUSION: FCE of the spinal cord, often mis-diagnosed as transverse myelitis, may be more common than presumed. Future research into FCE, including the development of a chondrolytic therapy that can be given empirically upon its clinical suspicion to acutely reverse its symptoms, may be of value.
No takes yet. Share an insight, caveat, or question.
AbdelRazek et al. (2015) conducted a review in Fibrocartilaginous Embolism (FCE) / Spinal cord infarction (n=67). Fibrocartilaginous Embolism was evaluated on Clinical anatomy, patho-physiologic mechanisms, epidemiology, diagnosis and treatment of FCE. A literature review identified 67 cases of fibrocartilaginous embolism, suggesting it is an under-diagnosed cause of spinal cord infarction often misdiagnosed as transverse myelitis.
Synapse has enriched 10 related papers. Consider them for comparative context: